AservoÆ EquiHalerÆ (ciclesonide inhalation spray) by Boehringer Ingelheim now able to be recycled through TerraCycleÆ across the U.S.
In its continuing commitment to global sustainability, Boehringer Ingelheim has partnered with international recycling leader TerraCycleÆ to create a recycling program for AservoÆ EquihalerÆ (ciclesonide inhalation spray). ASERVO EQUIHALER is the world’s first approved inhalant glucocorticoid therapy for horses suffering from severe equine asthma. This program will ensure the device will not contribute to the increasing problem of overcrowded landfills. As an additional incentive, for every ASERVO EQUIHALER device returned to TerraCycle, senders can earn points which can be donated to a non-profit, school or charitable organization of their choice.
Participation in the program is free and simple. Veterinarians and horse owners sign up at: https://www.terracycle.com/en-CA/brigades/equihaler, download the prepaid shipping label, affix the label to any box and ship the empty ASERVO EQUIHALER to TerraCycle. Once collected, the plastic material is melted down, pelletized and shaped into hard plastic to be used in creating new products such as shipping pallets and park benches.
The ASERVO EQUIHALER is designed for single, 10-day usage, making it important to be part of a recycling process. “This product is bringing great innovation to the equine industry for multiple reasons,” said Amanda McAvoy, Head of U.S. Equine Business. “It’s the first approved inhaled glucocorticoid treatment for horses with severe equine asthma, it is made from up to 50% recycled materials and is now able to be recycled through this collaboration with TerraCycle. We’re proud to continue being part of the team that is devoted to equine health care.”
ASERVO EQUIHALER IMPORTANT SAFETY INFORMATION: ASERVO EQUIHALER has not been evaluated in pregnant or lactating mares. In a large clinical field study, the most common adverse reactions reported were coughing, nasal discharge, sneezing and nasal irritation/bleeding. Not for use in humans. Keep this and all medications out of the reach of children.
“On the global level, Boehringer Ingelheim is committed to other sustainability practices such as the BE GREEN – Future by Choice Program that encompasses water stewardship, use of renewable energies and overall reductions in energy usage,” said McAvoy. “We are excited that the equine team in the U.S. can align with this global commitment.”
“The ASERVO EQUIHALER Recycling Program is a great example of a targeted waste stream that has huge potential to do great things both for animal health and sustainability in the veterinary industry,” said Tom Szaky, CEO and Founder of TerraCycle. “TerraCycle’s partnership with Boehringer Ingelheim marks an exciting opportunity to engage horse enthusiasts, animal lovers and veterinarians with sustainability in a way that hasn’t been done before.”
The ASERVO EQUIHALER Recylcing Program is open to any interested individual horse owner or veterinary practice.
ASERVO EQUIHALER IMPORTANT SAFETY INFORMATION: ASERVO EQUIHALER has not been evaluated in pregnant or lactating mares. In a large clinical field study, the most common adverse reactions reported were coughing, nasal discharge, sneezing and nasal irritation/bleeding. Not for use in humans. Keep this and all medications out of the reach of children.
